We are live on ! Find out more
O

Ossiam Portfolio holdings

AUM $5.69B
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
+30.95%
3 Year Est. Return
+104.81%
5 Year Est. Return
+127.55%
10 Year Est. Return
AUM
$2.39B
AUM Growth
+$825M
Cap. Flow
+$665M
Cap. Flow %
27.84%
Top 10 Hldgs %
39.85%
Holding
474
New
48
Increased
194
Reduced
166
Closed
61

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$90.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$73.8M
3
HD icon
Home Depot
HD
+$66.6M
4
NVDA icon
NVIDIA
NVDA
+$64.4M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$44.9M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$43.4M
2
QGEN icon
Qiagen
QGEN
+$14.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M
4
LIN icon
Linde
LIN
+$10.9M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 31.97%
2 Communication Services 19.4%
3 Financials 13.59%
4 Consumer Discretionary 11.94%
5 Healthcare 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
376
Mastercard
MA
$477B
$18K ﹤0.01%
54
-652
-92% -$212K
MDT icon
377
Medtronic
MDT
$107B
$17K ﹤0.01%
165
-3,983
-96% -$400K
ISRG icon
378
Intuitive Surgical
ISRG
$121B
$15K ﹤0.01%
+63
New +$14.1K
VRTX icon
379
Vertex Pharmaceuticals
VRTX
$121B
$14K ﹤0.01%
52
-2
-4% -$552
IDXX icon
380
Idexx Laboratories
IDXX
$42.9B
$12K ﹤0.01%
31
-155
-83% -$57.3K
CERN
381
DELISTED
Cerner Corp
CERN
$11K ﹤0.01%
149
-48,089
-100% -$3.43M
ILMN icon
382
Illumina
ILMN
$29.4B
$10K ﹤0.01%
33
-383
-92% -$132K
RMD icon
383
ResMed
RMD
$28.3B
$10K ﹤0.01%
61
-26
-30% -$4.8K
ACN icon
384
Accenture
ACN
$89.9B
$9K ﹤0.01%
40
-468
-92% -$107K
BMRN icon
385
BioMarin Pharmaceuticals
BMRN
$11.5B
$9K ﹤0.01%
119
-2,016
-94% -$204K
PAYC icon
386
Paycom
PAYC
$6.78B
$9K ﹤0.01%
28
-416
-94% -$122K
VMC icon
387
Vulcan Materials
VMC
$36.3B
$9K ﹤0.01%
69
-13,461
-99% -$1.69M
BSX icon
388
Boston Scientific
BSX
$65.8B
$8K ﹤0.01%
222
-67
-23% -$2.58K
SYK icon
389
Stryker
SYK
$127B
$8K ﹤0.01%
+39
New +$7.58K
DD icon
390
DuPont de Nemours
DD
$18.6B
$7K ﹤0.01%
96
-3,852
-98% -$270K
FIS icon
391
Fidelity National Information Services
FIS
$21.5B
$7K ﹤0.01%
45
-3,808
-99% -$550K
INTU icon
392
Intuit
INTU
$81.1B
$7K ﹤0.01%
20
-232
-92% -$72.6K
TXN icon
393
Texas Instruments
TXN
$255B
$7K ﹤0.01%
52
-628
-92% -$85.4K
ANSS
394
DELISTED
Ansys
ANSS
$6K ﹤0.01%
19
-211
-92% -$66.1K
COP icon
395
ConocoPhillips
COP
$147B
$6K ﹤0.01%
173
-590
-77% -$22.4K
IBM icon
396
IBM
IBM
$202B
$6K ﹤0.01%
50
-57,995
-100% -$6.83M
WDAY icon
397
Workday
WDAY
$33.4B
$6K ﹤0.01%
28
-1,151
-98% -$228K
ADP icon
398
Automatic Data Processing
ADP
$100B
$5K ﹤0.01%
33
-339
-91% -$47.5K
MELI icon
399
Mercado Libre
MELI
$91.3B
$5K ﹤0.01%
5
-92
-95% -$99.8K
PAYX icon
400
Paychex
PAYX
$40.4B
$5K ﹤0.01%
65
-635
-91% -$47.7K

Similar funds

Ossiam's Q3 2020 Portfolio in Review

As of Q3 2020, Ossiam held 474 positions worth $2.39B, up 53% from $1.56B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Ossiam deployed $665M of net new capital in Q3 2020, opening 48 new positions and adding to 194 existing holdings. Its largest new stake was Elevance Health: 20,000 shares worth $5.37M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Deutsche Bank, an estimated $43.4M trimmed.

  • Ossiam's largest Q3 2020 buy was Elevance Health: 20,000 shares worth $5.37M.
  • Ossiam added most to Microsoft in Q3 2020, an estimated $90.8M increase.
  • Ossiam's biggest Q3 2020 reduction was Deutsche Bank, cutting an estimated $43.4M.
  • Ossiam fully exited Blackrock in Q3 2020, selling an estimated $5.44M.
  • Ossiam's ten largest holdings make up 40% of its $2.39B portfolio in Q3 2020.
  • Ossiam opened 48 new positions and closed 61 in Q3 2020.
  • Ossiam's portfolio value rose 53% quarter-over-quarter to $2.39B.

Based on Ossiam's 13F filing for Q3 2020, filed 12 Nov 2020.